Keywords: گلیکوزآمینوگلیکان; Glycosaminoglycan; Chondroitin sulfate; Dermatan sulfate; Shark; RayCS, chondroitin sulfate; DS, dermatan sulfate; GAG, glycosaminoglycan; GlcA, glucuronic acid; GalNAc, N-acetyl-galactosamine; ΔO, ΔHexA(1–3)β-d-GalNAc; ΔA, ΔHexA(1–3)β-d-GalNAc(4S); ΔC, Δ
مقالات ISI گلیکوزآمینوگلیکان (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: گلیکوزآمینوگلیکان; ERT, enzyme replacement therapy; GAG, glycosaminoglycan; HSCT, hematopoietic stem cell transplantation; MPS, mucopolysaccharidosisElosulfase alfa; Enzyme replacement therapy; Mucopolysaccharidoses; Pregnancy
Keywords: گلیکوزآمینوگلیکان; Regenerative medicine; Cornea; Translational researchLEC, limbal epithelial crypts; LSCD, limbal stem-cell deficiency; COMET, cultivated oral mucosal epithelial cell sheet transplantation; iPS, induced pluripotent stem; GAG, glycosaminoglycan; PMD Act, Ac
Keywords: گلیکوزآمینوگلیکان; EKA, electrokinetic analysis; QCM-D, quartz crystal microbalance with dissipation; SPR, surface plasmon resonance; LbL, layer-by-layer; PE, polyelectrolyte; GAG, glycosaminoglycan; PLL, poly-l-lysine; HA, hyaluronic acid; ChS, chondroitin sulfate; Hep, he
Keywords: گلیکوزآمینوگلیکان; ECM, extracellular matrix; GAG, glycosaminoglycan; PG, proteoglycan; HS, heparan sulfate; Hep, heparin; nM-Hep, nano-mammalian heparin; nS-Hep, nano-Styela heparin; CS, chondroitin sulfate; NPs, nanoparticles; FBS, fetal bovine serum; IL-6, interleukin-6;
Keywords: گلیکوزآمینوگلیکان; CDG, congenital disorders of glycosylation; COG, conserved oligomeric Golgi; ER, endoplasmic reticulum; GAG, glycosaminoglycan; GlcNAc, β-N-acetylglucosamine; LLO, lipid-linked oligosaccharide; RNAi, RNA interference; TGN, trans-Golgi networkprotein glyco
Keywords: گلیکوزآمینوگلیکان; Glycosaminoglycans; High energy shock wave; Osteogenesis; Bone fractures therapyBMP, bone morphogenic protein; Cetavlon, cetyl trimethylammonium bromide; CS, chondroitin sulfate; ELISA, enzyme-linked immunosorbent assay; GAG, glycosaminoglycan; HA, hyalur
Keywords: گلیکوزآمینوگلیکان; α2M, α2-macroglobulin; ADAMTS, adamalysin-like metalloproteinase with thrombospondin motifs; ECM, extracellular matrix; GAG, glycosaminoglycan; LAP, latency associated peptide; LRP1, low-density lipoprotein receptor-related protein 1; OA, osteoarthritis;
Keywords: گلیکوزآمینوگلیکان; Hyaluronan; Chondroitin sulfate; Oligosaccharide; Hyaluronidase; InhibitorHA, hyaluronan; ChS, chondroitin sulfate; GAG, glycosaminoglycan; PG, proteoglycan; BTH, bovine testicular hyaluronidase; Ch4S, chondroitin 4-sulfate; Ch6S, chondroitin 6-sulfate; C
Keywords: گلیکوزآمینوگلیکان; LA, local anaesthetic; RCT, randomised controlled trial; PP, pain pump; PAGCL, post-arthroscopic glenohumeral chondrolysis; TKA, total knee athroplasty; PBS, phosphate buffered saline; MgSO4, magnesium sulphate; GAG, glycosaminoglycan; PG, proteoglycan; L
Keywords: گلیکوزآمینوگلیکان; Hapln, hyaluronan and proteoglycanbinding link protein; CNS, central nervous system; WFA, Wisteria floribunda agglutinin; CSPG, chondroitin sulfate proteoglycans; ECM, extracellular matrix; GAG, glycosaminoglycan; TN-R, tenascin-R; HAS, hyaluronan synthas
Keywords: گلیکوزآمینوگلیکان; Cisplatin (PubChemCID: 2767); Tinzaparin (PubChemCID: 25244225); Fordaparinux (PubChemCID: 5282448); Enoxaparin (PubChemCID 57199466)CTR1, copper transporter-1; GAG, glycosaminoglycan; GPC3, glypican-3; HSPG, heparan sulfate proteoglycan; LMWH, low molecu
Keywords: گلیکوزآمینوگلیکان; ECM, extracellular matrix; GAG, glycosaminoglycan; HSPG, heparan sulfate proteoglycan; Hepsmaf, small subunit of human heparanase; Heplaf, large subunit of human heparanaseHuman heparanase; Angiogenesis; Tumor metastasis; Extracellular matrix; Heparan sul
Keywords: گلیکوزآمینوگلیکان; DS, dermatan sulfate; ECM, extracellular matrix; ERT, enzyme replacement therapy; GAG, glycosaminoglycan; HSCT, hematopoietic stem cell therapy; HS, heparan sulfate; I2S, iduronate 2-sulfatase; LSD, lysosomal storage disorder; MPS II, mucopolysaccharidosi
Keywords: گلیکوزآمینوگلیکان; DS, dermatan sulfate; ECM, extracellular matrix; ERT, enzyme replacement therapy; GAG, glycosaminoglycan; HSCT, hematopoietic stem cell therapy; HS, heparan sulfate; I2S, iduronate 2-sulfatase; LSD, Lysosomal storage disorder; MPS II, mucopolysaccharidosi
Keywords: گلیکوزآمینوگلیکان; CS, chondroitin sulfate; DS, dermatan sulfate; HA, hyaluronic acid; HS, heparan sulfate; GAG, glycosaminoglycan; KS, keratan sulfate; MPS, mucopolysaccharidosis; TFEB, transcription factor EBCell cycle; Fibroblasts; Genistein; Mucopolysaccharidoses
Keywords: گلیکوزآمینوگلیکان; LSD, lysosomal storage diseases; MPS, mucopolysaccharidoses; PND, prenatal diagnosis; GAG, glycosaminoglycan; AMF, amniotic fluid; 2-DE, 2-dimensional electrophoresis; CS, chondroitin sulphate; HA, hyaluronic acid; DS, dermatan sulphate; IDS, iduronate-2-
The diagnostic journey of patients with mucopolysaccharidosis I: A real-world survey of patient and physician experiences
Keywords: گلیکوزآمینوگلیکان; Card, cardiologist; ENT, ear nose and throat; ERT, enzyme replacement therapy; EU, Europe; GAG, glycosaminoglycan; Gen Pract, general practitioner; Gen/Met Dis, geneticist/metabolic disease specialist; HSCT, hematopoietic stem cell transplant; IDUA, α-l-i
Long-term galsulfase enzyme replacement therapy in Taiwanese mucopolysaccharidosis VI patients: A case series
Keywords: گلیکوزآمینوگلیکان; MPS, mucopolysaccharidosis; ASB, N-acetylgalactosamine 4-sulfatase; GAG, glycosaminoglycan; ERT, enzyme replacement therapy; Galsulfase, recombinant human N-acetylgalactosamine 4-sulfatase; Z score, standard deviation score; 6MWT, 6-minute walk test; 3MSC
Cathepsin-L and transglutaminase dependent processing of ps20: A novel mechanism for ps20 regulation via ECM cross-linking
Keywords: گلیکوزآمینوگلیکان; WFDC1, whey acidic protein four disulphide core 1; GAG, glycosaminoglycan; ps20, prostate stromal 20; rps20, recombinant ps20; FL, full length; TR, truncated; MW, molecular weight; HMW, high molecular weight; LMW, low molecular weight; ECM, extracellular
The role of heparan sulfate as determining pathogenic factor in complement factor H-associated diseases
Keywords: گلیکوزآمینوگلیکان; FH, complement factor H; HS, heparan sulfate; AP, alternative pathway; CCP, complement control protein domain; GAG, glycosaminoglycan; AMD, age-related macular degeneration; DDD, dense deposit disease; aHUS, atypical hemolytic uremic syndrome; dpX, degree
Acellular matrix in urethral reconstruction
Keywords: گلیکوزآمینوگلیکان; LS, Lichen sclerosis; PGA, polyglycolic acid; SIS, small intestinal submucosa; GAG, glycosaminoglycan; UAMG, urethral acellular matrix grafts; ECM, extracellular matrix.Tissue engineering; Scaffold; Graft; Regeneration; Urethroplasty
Mutations in ARSB in MPS VI patients in India
Keywords: گلیکوزآمینوگلیکان; ARSB, arylsulfatase B; ERT, enzyme replacement therapy; GALNS, N-acetyl galactosamine 6-sulfatase; GAG, glycosaminoglycan; HSCT, hematopoietic stem cell transplantation; HGMD, Human Gene Mutation Database; LSD, lysosomal storage disorder; MPS, mucopolysac
Development of a fluorometric microtiter plate based enzyme assay for MPS IVA (Morquio type A) using dried blood spots
Keywords: گلیکوزآمینوگلیکان; 4-MU, 4-methylumbelliferone; 4-MU-β-gal-S, 4-methylumbelliferyl-β-d-galactopyranoside sulfate sodium salt; β-Gal, β-galactosidase; BSA, bovine serum albumin; DBS, dried-blood spot; ERT, enzyme replacement therapy; GAG, glycosaminoglycan; GALNS, n-acetylga
Immunosuppressants increase the levels of natural autoantibodies reactive with glycosaminoglycans in myasthenia gravis
Keywords: گلیکوزآمینوگلیکان; AChR, acetylcholine receptor; ANOVA, analysis of variances; CSA, chondroitin-sulphate A; CSB, chondroitin-sulphate B; CSC, chondoroitin-sulphate C; GAG, glycosaminoglycan; HA, hyaluronic acid; HS, heparane-sulphate; IS, immunosuppressant; MG, myasthenia g
Promoting increased mechanical properties of tissue engineered neocartilage via the application of hyperosmolarity and 4α-phorbol 12,13-didecanoate (4αPDD)
Keywords: گلیکوزآمینوگلیکان; TRPV4, transient receptor potential vanilloid 4; 4αPDD, 4α-phorbol 12,13-didecanoate; ECM, extracellular matrix; GAG, glycosaminoglycan; MMP, matrix metalloproteinaseNeocartilage; Cartilage tissue engineering; Dynamic loading; Self-assembly; Scaffold-free
Auto-associative heparin nanoassemblies: A biomimetic platform against the heparan sulfate-dependent viruses HSV-1, HSV-2, HPV-16 and RSV
Keywords: گلیکوزآمینوگلیکان; ATR-FTIR, Attenuated total reflectance-Fourier transform infrared; CC50, cytotoxic concentrations; CIs, confidence intervals; CNRS, Centre National de la recherche Scientifique; DCM, dichloromethane; DMF, dimethylformamide; GAG, glycosaminoglycan; HPV, hu
Characterisation of hyaluronic acid and chondroitin/dermatan sulfate from the lumpsucker fish, C. lumpus
Keywords: گلیکوزآمینوگلیکان; GAG, glycosaminoglycan; DS, dermatan sulfate; CS, chondroitin sulfate; HA, hyaluronic acid; KS, keratan sulfate; HS, heparan sulfate; GlcA, glucuronic acid; IdoA, iduronic acid; GalNAc, N-acetylated galactosamineCyclopterus lumpus; Chondroitin sulfate; De
Structure, function, aging and turnover of aggrecan in the intervertebral disc
Keywords: گلیکوزآمینوگلیکان; GAG, glycosaminoglycan; KS, keratan sulfate; HA, hyaluronic acid; IGD, interglobular domain; MMPs, metalloproteinases; CS, chondroitin sulfate; IVD, intervertebral disc; EGF, epidermal growth factor; CRP, complement regulatory protein; ECM, extracellular
Divergent effect of glycosaminoglycans on the in vitro aggregation of serum amyloid A
Keywords: گلیکوزآمینوگلیکان; GAGs; Reactive amyloidosis; Inflammation; Fibrillation kineticsAA, amyloid A; AFM, atomic force microscopy; apo, HDL-free; CD, circular dichroism; CSA, chondroitin sulfate A; GAG, glycosaminoglycan; HA, hyaluronic Acid; Hep, heparin; Hepa, heparosan; HS,
Glycosaminoglycan mimetic improves enrichment and cell functions of human endothelial progenitor cell colonies
Keywords: گلیکوزآمینوگلیکان; GAG, glycosaminoglycan; HBGF, heparin binding growth factor; HS, heparan sulfate; CS, chondroitin sulfate
Interference with the contractile machinery of the fibroblastic chondrocyte cytoskeleton induces re-expression of the cartilage phenotype through involvement of PI3K, PKC and MAPKs
Keywords: گلیکوزآمینوگلیکان; ERK, extracellular signaling regulated kinase; GAG, glycosaminoglycan; MEK, mitogen-activated protein kinase kinase; ILK, integrin-linked kinase; MAPK, mitogen-activated protein kinase; PI3K, phosphoinositide-3-kinase; PKC, protein kinase CStaurosporine;
Mass preparation of oligosaccharides by the hydrolysis of chondroitin sulfate polysaccharides with a subcritical water microreaction system
Keywords: گلیکوزآمینوگلیکان; CS, chondroitin sulfate; CSase, chondroitinase; GalNAc, N-acetyl-d-galactosamine; GlcA, d-glucuronic acid; GAG, glycosaminoglycan; ΔHexA, 4-deoxy-α-l-threo-hex-4-enepyranosyluronic acid; 2S, 2-O-sulfate; 4S, 4-O-sulfate; 6S, 6-O-sulfateChondroitin sulfate
Sulfation of keratan sulfate proteoglycan reduces radiation-induced apoptosis in human Burkitt’s lymphoma cell lines
Keywords: گلیکوزآمینوگلیکان; CS, chondroitin sulfate; FGF, fibroblast growth factor; GAG, glycosaminoglycan; Gal, galactose; GlcNAc, N-acetylglucosamine; GlcNAc6ST, N-acetylglucosamine-6-O-sulfotransferase; HS, heparin sulfate; KS, keratan sulfate; MAPK, mitogen-activated protein kin
Physiological Relevance of LL-37 Induced Bladder Inflammation and Mast Cells
Keywords: گلیکوزآمینوگلیکان; urinary bladder; mast cells; meningomyelocele; cystitis; interstitial; inflammationDAB, diaminobenzidine; GAG, glycosaminoglycan; IC/PBS, interstitial cystitis/painful bladder syndrome; MM/SB, myelomeningocele/spina bifida; MPO, myeloperoxidase; t, time;
Nephronectin binds to heparan sulfate proteoglycans via its MAM domain
Keywords: گلیکوزآمینوگلیکان; CBM, carbohydrate-binding module; CS, chondroitin sulfate; ECM, extracellular matrix; EGF, epidermal growth factor; ERK, extracellular signal-regulated kinase; FGF, fibroblast growth factor; FS, Fraser syndrome; GAG, glycosaminoglycan; HRP, horseradish pe
Immobilization of chondroitin sulfate to lipid membranes and its interactions with ECM proteins
Keywords: گلیکوزآمینوگلیکان; GAG, glycosaminoglycan; ECM, extracellular matrix; CS, chondroitin sulfate; QCM-D, Quartz Crystal Microbalance with Dissipation monitoring; SLB, supported lipid bilayer; BMP-2, bone morphogenetic protein-2; EDC, N-(3-dimethylaminopropyl)-N′-ethylcarbodiim
Smad2-dependent glycosaminoglycan elongation in aortic valve interstitial cells enhances binding of LDL to proteoglycans
Keywords: گلیکوزآمینوگلیکان; CAVD, calcific aortic valve disease; GAG, glycosaminoglycan; LDL, low-density lipoprotein; pSmad2/3, phosphorylated Smad2/3; TGF-β1, transforming growth factor; VIC, valve interstitial cellHeart valves; Smad; Transforming growth factor-β; Lipids; Glycosam
Back pain in space and post-flight spine injury: Mechanisms and countermeasure development
Keywords: گلیکوزآمینوگلیکان; IVD, intervertebral disc; HNP, herniated nucleus pulposus; MET, medical exercise therapy; STEP, scientific therapeutic exercise progressions; ISS, International Space Station; PG, proteoglycan; GAG, glycosaminoglycan; PLL, posterior longitudinal ligament;
Genistein reduces heparan sulfate accumulation in human mucolipidosis II skin fibroblasts
Keywords: گلیکوزآمینوگلیکان; DAPI, 4′,6-diamidino-2-phenylindole; DMSO, dimethyl sulfoxide; EGF, epidermal growth factor; FGF, fibroblast growth factor; FGFR2, fibroblast growth factor receptor 2; GAG, glycosaminoglycan; HS, heparan sulfate; ML-II, mucolipidosis II; MPS, mucopolysacc
Specific antibody titer alters the effectiveness of intrathecal enzyme replacement therapy in canine mucopolysaccharidosis I
Keywords: گلیکوزآمینوگلیکان; rhIDU, EC 3.2.1.76, Recombinant human alpha-l-idurondiase; MPS, mucopolysaccharidosis; IT, intrathecal; GAG, glycosaminoglycan; pGAG, pathologic GAG; tGAG, total GAG; NRE, non-reducing end; ELISA, enzyme-linked immunosorbent assayMucopolysaccharidosis; Ly
Wild blueberry (V. angustifolium)-enriched diets alter aortic glycosaminoglycan profile in the spontaneously hypertensive rat
Keywords: گلیکوزآمینوگلیکان; C, control; CVD, cardiovascular disease; CS, chondroitin sulfate; DS, dermatan sulfate; ECM, extracellular matrix; GalAG, galactosaminoglycan; GAG, glycosaminoglycan; HA, hyaluronic acid; HPCE, high-performance capillary electrophoresis; HS, heparan sulfa
Whole-exome sequencing in a single proband reveals a mutation in the CHST8 gene in autosomal recessive peeling skin syndrome
Keywords: گلیکوزآمینوگلیکان; GalNAc4-ST, N-acetylgalactosamine-4-O-sulfotransferase; PSS, peeling skin syndrome; APSS, acral peeling skin syndrome; GAG, glycosaminoglycan; TGM5, tranglutaminase 5; CDSN, corneodesmosin; NS, Netherton syndrome; CSTA, cystatin A; DMMB, 1,9-dimethylmethy
Fibroblast growth factor 2 enhances the kinetics of mesenchymal stem cell chondrogenesis
Keywords: گلیکوزآمینوگلیکان; ACAN, aggrecan; B2M, β2-microglobulin; Col I, type I collagen; Col II, type II collagen; Col X, type X collagen; DMMB, dimethyl-methylene blue; FGF-2, fibroblast growth factor 2; GAG, glycosaminoglycan; GDF, growth differentiation factor; MSC, mesenchymal
Dissection of inflammatory processes using chemokine biology: Lessons from clinical models
Keywords: گلیکوزآمینوگلیکان; B1a, CD5(+) B-1 cells; BOS, bronchiolitis obliterans syndrome; CD, cluster determinant; CNS, central nervous system; DC, dendritic cell; DSS, dextran sodium sulfate; EAE, experimental autoimmune encephalomyelitis; GAG, glycosaminoglycan; GVHD, graft-versu
Serum xylosyltransferase 1 level increases during early posttraumatic osteoarthritis in mice with high bone forming potential
Keywords: گلیکوزآمینوگلیکان; BMD, bone mineral density; B6, C57BL/6J; C3H, C3H/HeJ; DMM, destabilization of the medial meniscus; GAG, glycosaminoglycan; OA, osteoarthritis; PG, proteoglycan; MNX, meniscectomy; Xylt1, xylosyltransferase 1Cartilage; Osteoarthritis; Biomarkers; Xylosylt
Genetic structure and polymorphisms of the N16 gene in Pinctada fucata
Keywords: گلیکوزآمینوگلیکان; OM, organic matrix; CTAB, hexadecyltrimethylammonium bromide; EDTA, ethylenediaminetetraacetic acid; CIA, chloroform–isoamyl alcohol (24:1); GAG, glycosaminoglycan; S, serine; H, histidine; Q, glutamine; F, phenylalanine; R, arginine; T, threonine; V, val
Potentiation of C1-esterase inhibitor by heparin and interactions with C1s protease as assessed by surface plasmon resonance
Keywords: گلیکوزآمینوگلیکان; Anti-C1-INH ab, anti-C1-esterase inhibitor antibody; α1-PI, α1-proteinase inhibitor; ATIII, antithrombin; C1-INH, C1-esterase inhibitor; CD, circular dichroism; DMSO, dimethyl sulfoxide; GAG, glycosaminoglycan; L/P, ligand-to-protein molar ratio; PBS, pho
Overview of the mechanisms regulating chemokine activity and availability
Keywords: گلیکوزآمینوگلیکان; CCX-CKR, chemocentryx chemokine receptor; DARC, Duffy antigen receptor for chemokines; GAG, glycosaminoglycan; HIV, human immuno-deficiency virus; IFN, interferon; IL, interleukin; MMP, matrix metalloprotease; PAD, peptidylarginine deiminase; PRR, pattern
Critical amino acids in syndecan-4 cytoplasmic domain modulation of turkey satellite cell growth and development
Keywords: گلیکوزآمینوگلیکان; BF, Brightfield; BSA, bovine serum albumin; DMEM, Dulbecco's Modified Eagle Medium; EGFP, enhanced green fluorescence; FGF2, fibroblast growth factor 2; GAG, glycosaminoglycan; GAPDH, Glyceraldehyde-3-phosphate dehydrogenase; M-MLV, leukemia virus reverse